DEVELOPMENT AND VALIDATION OF A GC-HS-FID METHOD FOR DIMETHYL SULFATE IN CLOBAZAM API: INTEGRATION OF (Q)SAR-BASED GENOTOXICITY ASSESSMENT
DOI:
https://doi.org/10.22159/ijap.2026v18i3.57382Keywords:
Dimethyl sulfate, Genotoxic impurity, ICH M7, Quantitative structure–activity relationship, Clobazam, Gas chromatography-headspace, Trace analysisAbstract
Objective: To develop and validate a sensitive gas chromatography–headspace method with flame ionisation detection (GC–HS–FID) for trace-level quantification of dimethyl sulfate (DMS) in clobazam active pharmaceutical ingredient (API), supported by an in silico quantitative structure-activity relationship ((Q)SAR) based genotoxicity assessment in accordance with International Council for Harmonisation (ICH) M7(R1).
Methods: DMS was derivatised to anisole using phenol under alkaline conditions in a dimethylformamide–water diluent and analysed by GC–HS–FID. The method was validated in accordance with ICH Q2(R1) guidelines. Mutagenicity was evaluated using VEGA (Q)SAR models within their applicability domains.
Results: The method demonstrated high specificity with no interference at the anisole retention time. Linearity was observed over the studied concentration range (R² = 0.9993). The limit of detection and limit of quantification were 0.04 ppm and 0.12 ppm, respectively. Precision and accuracy met ICH acceptance criteria, and the method remained robust under minor variations in chromatographic conditions. In silico (Q)SAR analysis consistently predicted dimethyl sulfate as mutagenic within the applicability domain.
Conclusion: The validated GC–HS–FID method is sensitive and reliable for routine monitoring of dimethyl sulfate in clobazam API. The in silico (Q)SAR assessment corroborates its classification as a Class 1 genotoxic impurity (GTI), supporting the need for stringent control.
References
1. Selva M, Perosa A. Green chemistry metrics: a comparative evaluation of dimethyl carbonate, methyl iodide, dimethyl sulfate and methanol as methylating agents. Green Chem. 2008;10(4):457–64. doi:10.1039/b713985c
2. de Souza Freitas M, Nelson DL, de Sousa JV, Wentz AP, Tada DB, Queiroz RC, et al. Dimethyl sulfate as methylation agent and solvent in highly regioselectivesynthesis of methyl salicylate using sodium bicarbonate as a base. ACS Omega. 2025;10(13):13260–8. doi:10.1021/acsomega.4c10962
3. Rahman MH, Gullick DR, Hoerner J, Bartlett MG. Determination of genotoxic impurities, monomethyl sulfate and dimethyl sulfate in active pharmaceutical ingredients. Anal Methods. 2017;9(7):1112–8. doi:10.1039/c7ay00044h
4. Szekely G, Amores de Sousa MC, Gil M, et al. Genotoxic impurities in pharmaceutical manufacturing: sources, regulations and mitigation. Chem Rev. 2015;115(16):8182–229. doi:10.1021/cr300095f
5. Patel AB, Asnani AH, Vyas AJ, et al. A brief review on genotoxic impurities in pharmaceuticals. Asian J Pharm Res. 2021;11(3):187–93. doi:10.52711/2231-5691.2021.00034
6. Snodin DJ. Genotoxic impurities: a regulatory toxicology commentary on recent articles in organic process research and development. Org Process Res Dev. 2011;15(6):1243–6. doi:10.1021/op200205b
7. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). M7(R1): assessment and control of DNA-reactive (mutagenic) impurities in pharmaceuticals [Internet]. Geneva: ICH; 2017 [cited 2025 Dec 6]. Available from: https://database.ich.org/sites/default/files/M7_R1_Guideline.pdf
8. U.S. Environmental Protection Agency (EPA). IRIS chemical assessment summary for dimethyl sulfate (CASRN 77-78-1) [Internet]. Washington (DC): National Center for Environmental Assessment, Office of Research and Development; 1988 Sep 7 [cited 2025 Dec 6]. Available from: https://iris.epa.gov/ChemicalLanding/&substance_nmbr=365
9. Mathison BH, Taylor ML, Bogdanffy MS. Dimethyl sulfate uptake and methylation of DNA in rat respiratory tissues following acute inhalation. FundamApplToxicol. 1995;28(2):255–63. doi:10.1006/faat.1995.1166
10. Mereyala HB, Sambasiva Rao KRS, Reddy PG. Process for the preparation of clobazam and intermediates thereof. United States patent US 7,884,196 B2. 2011 Feb 8.
11. Kumar N, Devineni SR, Bhat S, Madhavi G, Dubey SK, Reddy KJ, et al. Potential impurities of the anti-epileptic drug clobazam: synthesis and characterisation. Lett Org Chem. 2017;14(10):769-77. doi:10.2174/1570178614666170623122150
12. Lewis H. Methylation of phenol by dimethyl sulfate. IndEng Chem. 1930;22(4):397–8. doi:10.1021/ie50244a030
13. Hiers G, Hager F. Anisole. Org Synth. 1941;1:58–9. doi:10.15227/orgsyn.009.0012
14. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Q3C(R8): impurities guideline for residual solvents [Internet]. Geneva: ICH; 2021 [cited 2025 Dec 6]. Available from: https://database.ich.org/sites/default/files/ICH_Q3C-R8_Guideline_Step4_2021_0422_1.pdf
15. Lu R. Determination of residual dimethyl sulfate in cephalosporins using HS-SPME/GC-MS. J Chromatogr Sci. 2024;62(10):922–8. doi:10.1093/chromsci/bmae054
16. Çeğil T, Yardımcı A, Sevinç N, Pamukçu Z. Determination of dimethyl sulfate genotoxic impurity in pantoprazole sodium sesquihydrate by derivatisation method and UPLC/MS. Int J Mass Spectrom. 2024;506:117330. doi:10.1016/j.ijms.2024.117330
17. Grinberg N, Albu F, Fandrick K, et al. Assay at low ppm level of dimethyl sulfate in starting materials for API synthesis using derivatisation in ionic liquid media and LC–MS. J Pharm Biomed Anal. 2013;75:1–6. doi:10.1016/j.jpba.2012.11.016
18. Seymour M. Determination of residual dimethyl sulfate in a lipophilic bulk drug by wide-bore capillary gas chromatography. J Chromatogr A. 1989;463:216–21. doi:10.1016/S0021-9673(01)84474-5
19. Petha NH, Lode RS, Seshadri DT, et al. Determination of residual dimethyl sulfate in hexaconazole (fungicide) by headspace gas chromatography–mass spectrometry. Microchem J. 2017;133:506–10. doi:10.1016/j.microc.2017.04.016
20. Zheng J, Pritts WA, Zhang S, Wittenberger S. Determination of low ppm levels of dimethyl sulfate in an aqueous-soluble API intermediate using liquid–liquid extraction and GC-MS. J Pharm Biomed Anal. 2009;50(5):1054–9. doi:10.1016/j.jpba.2009.06.022
21. Khan M, Jayasree K, Reddy KK, Dubey PK. A validated CE method for determining dimethyl sulfate, a carcinogen, and chloroacetyl chloride at trace levels in drugs. J Pharm Biomed Anal. 2012;58:27–33. doi:10.1016/j.jpba.2011.09.019
22. Anerao AJ, Patil BH, Pradhan NI. Determination of residual dimethyl sulfate in methoxsalen by pre-column derivatisation with static headspace gas chromatography. Int J Pharm Pharm Sci. 2018;10:84–9. doi:10.22159/ijpps.2018v10i8.27670
23. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Q2(R1): validation of analytical procedures: text and methodology [Internet]. Geneva: ICH; 2005 [cited 2025 Dec 6]. Available from: https://database.ich.org/sites/default/files/Q2(R1)_Guideline.pdf
24. Benfenati E, Manganaro A, Gini G. VEGA-QSAR: AI inside a platform for predictive toxicology. SAR QSAR Environ Res. 2013;24(7):661-71. doi:10.1080/1062936X.2013.802672
25. Sutnga VS, Selvakumar K, Rajesh R. A review on analytical challenges in monitoring and controlling genotoxic impurities. Asian J Pharm Clin Res. 2020;13(10):10–15.
doi:10.22159/ajpcr.2020.v13i10.38847
26. Aparna K, Vijaya Rachel K, Narayana Rao KM. Quantitative determination of methyl-4-chlorobutyrate, a potential genotoxic impurity, in moxifloxacin hydrochloride by GC–EI–MS. Int J Appl Pharm. 2024;16(5):234–241. doi:10.22159/ijap.2024v16i5.51551.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Srinivas Birudukota, Dr. SWAGATA HALDER , Dr.RAMESHA ANDAGAR RAMAKRISHNA
This work is licensed under a Creative Commons Attribution 4.0 International License.